ROS1 was highly differentially expressed across tumor samples: mRNA levels were high (Cycle Threshold, Ct < 32) in 63% and low (Cycle Threshold, Ct > 32) in 38% of samples. This evidence concerns the gene ROS1 and neoplasm.